Post Resch Tallon Group Inc. Zomedica Corp. Transaction History
Post Resch Tallon Group Inc.
- $98 Billion
- Q1 2025
A detailed history of Post Resch Tallon Group Inc. transactions in Zomedica Corp. stock. As of the latest transaction made, Post Resch Tallon Group Inc. holds 150,000 shares of ZOM stock, worth $9,000. This represents 0.01% of its overall portfolio holdings.
Number of Shares
150,000
Previous 150,000
-0.0%
Holding current value
$9,000
Previous $20.7 Million
57.31%
% of portfolio
0.01%
Previous 0.02%
Shares
1 transactions
Others Institutions Holding ZOM
# of Institutions
27Shares Held
16.3MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY9.86MShares$591,7780.0% of portfolio
-
Ancora Advisors, LLC Cleveland, OH4.72MShares$283,2070.01% of portfolio
-
Orion Portfolio Solutions, LLC357KShares$21,4290.0% of portfolio
-
Advisory Services Network, LLC297KShares$17,8170.0% of portfolio
-
Spire Wealth Management218KShares$13,1080.0% of portfolio
About Zomedica Corp.
- Ticker ZOM
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 979,950,016
- Market Cap $58.8M
- Description
- Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment...